Wellington Management related stories
All articles and analysis
VC-backed CytomX Therapeutics files for IPOSouth San Francisco-based CytomX Therapeutics, a biopharmaceutical company focused on treating cancer, has filed for an IPO. The number of shares that will be sold as well as the stock's pricing terms have yet to be determined. The company plans on trading the stock on the NASDAQ under the ticker symbol "CTMX." BofA Merrill Lynch, Jefferies LLC and Cowen and Company LLC will serve as the lead underwriters. CytomX's backers include Fidelity Management & Research Company, Casdin Capital, Cormorant Asset Management, Deerfield Management, Perceptive Advisors, Redmile Group, Tekla Healthcare Investors and Tekla Life Sciences Investors, Venrock Healthcare Capital Partners and Wellington Management Company.
IPO Aftermarket: Life sciences keep dominating as Pure Storage files its IPOThrough the end of July, VCJ reports that 50 VC-backed companies have gone public on the NYSE or Nasdaq exchanges
- Payoneer nabs $50 mln
New York-based payments platform Payoneer Inc has secured $50 million in funding. Wellington Management Company led the round with participation from other investors that included Susquehanna Growth Equity LLC.
- Rhythm Metabolic racks up $40 mln Series A
Boston-based Rhythm Metabolic, a subsidiary of Rhythm, has closed $40 million in Series A funding. The investors included OrbiMed, Deerfield Management, Wellington Management Company, MPM Capital, New Enterprise Associates, Third Rock Ventures, Pfizer Ventures and Ipsen. In conjunction with the funding, Jonathan Silverstein of OrbiMed has been appointed to Rhythm Metabolic's board of directors. Rhythm Metabolic is focused on treating obesity caused by genetic deficiencies.
- Data storage company Pure Storage files for IPO: Reuters
Pure Storage Inc filed with U.S. regulators on Wednesday for an initial public offering of common stock, a year after a private placement valued the data storage company at more than $3 billion, Reuters News reported.
- VC-backed GBT goes public
South San Francisco-based Global Blood Therapeutics Inc, a biopharmaceutical company focused on treating blood-based disorders, has raised $120 million for its IPO after pricing its 6 million shares at $20 per share. The stock began trading Wednesday on the NASDAQ under the ticker symbol "GBT." Morgan Stanley and Goldman Sachs are serving as the lead underwriters. GBT's backers included Wellington Management Company, RA Capital, Deerfield Management, Sabby Capital and Perceptive Life Sciences.
- Wellington Management leads Series C round for Harry's
According to a source familiar with the company, HF Global Inc, parent company of men's grooming brand Harry's, has raised $75.6 million in Series C funding. Wellington Management led the round with participation from return backer Tiger Global. The capital infusion will be used for expansion, research and development and product development.
- CytomX attracts $70 mln Series D
South San Francisco-based CytomX, a developer of Probody therapeutics that treat cancer, has raised $70 million in Series D funding. Fidelity Management & Research Company led the round with participation from other investors that included Casdin Capital, Cormorant Asset Management, Deerfield Management, Perceptive Advisors, Redmile Group, Tekla Healthcare Investors and Tekla Life Sciences Investors, Venrock Healthcare Capital Partners and Wellington Management Company.
- TabbedOut snaps up $21.5 mln Series C
TabbedOut, a mobile payment app for bars and restaurants, has raised $21.5 million in Series C funding. Wellington Management Company led the round with participation from return backers New Enterprise Associates and Morgan Creek Capital Management.
- VC-backed Nivalis files for IPO
Boulder, Colorado-based Nivalis Therapeutics, a developer of drugs for patients with cystic fibrosis, has filed for an IPO. The number of shares that will be sold as well as the stock's pricing terms have yet to be set. Nivalis plans on trading the stock on the NASDAQ under the ticker symbol "NVLS." Cowen and Company and Stifel are serving as lead underwriters. The company's backers include Apple Tree Partners, Deerfield, RA Capital, Rock Springs Capital and Wellington Management.